BACKGROUND: Resveratrol have been shown to exert an antiinflammatory and antiaging effects in vitro and in animal models. OBJECTIVE: The objective of the study was to investigate the effect of a Polygonum cuspidatum extract (PCE) containing resveratrol on oxidative and inflammatory stress in normal subjects. RESEARCH DESIGN AND METHODS: Two groups (10 each) of normal-weight healthy subjects were randomized to placebo or PCE containing 40 mg resveratrol daily for 6 wk. Fasting blood samples were obtained prior to and after treatment at 1, 3, and 6 wk. Mononuclear cells were prepared for reactive oxygen species generation, RNA isolation, nuclear extract, and total cell homogenate preparation. Indices of oxidative and inflammatory stress, suppressor of cytokine signaling-3, phosphotyrosine phosphatase-1B, jun-N-terminal kinase-1, and inhibitor of kappaB-kinase-beta were measured by RT-PCR and Western blotting. RESULTS: The extract induced a significant reduction in reactive oxygen species generation, the expression of p47(phox), intranuclear nuclear factor-kappaB binding, and the expression of jun-N-terminal kinase-1, inhibitor of kappaB-kinase-beta, phosphotyrosine phosphatase-1B, and suppressor of cytokine signaling-3 in mononuclear cells when compared with the baseline and the placebo. PCE intake also suppressed plasma concentrations of TNF-alpha, IL-6, and C-reactive protein. There was no change in these indices in the control group given placebo. CONCLUSIONS: The PCE-containing resveratrol has a comprehensive suppressive effect on oxidative and inflammatory stress.
RCT Entities:
BACKGROUND:Resveratrol have been shown to exert an antiinflammatory and antiaging effects in vitro and in animal models. OBJECTIVE: The objective of the study was to investigate the effect of a Polygonum cuspidatum extract (PCE) containing resveratrol on oxidative and inflammatory stress in normal subjects. RESEARCH DESIGN AND METHODS: Two groups (10 each) of normal-weight healthy subjects were randomized to placebo or PCE containing 40 mg resveratrol daily for 6 wk. Fasting blood samples were obtained prior to and after treatment at 1, 3, and 6 wk. Mononuclear cells were prepared for reactive oxygen species generation, RNA isolation, nuclear extract, and total cell homogenate preparation. Indices of oxidative and inflammatory stress, suppressor of cytokine signaling-3, phosphotyrosine phosphatase-1B, jun-N-terminal kinase-1, and inhibitor of kappaB-kinase-beta were measured by RT-PCR and Western blotting. RESULTS: The extract induced a significant reduction in reactive oxygen species generation, the expression of p47(phox), intranuclear nuclear factor-kappaB binding, and the expression of jun-N-terminal kinase-1, inhibitor of kappaB-kinase-beta, phosphotyrosine phosphatase-1B, and suppressor of cytokine signaling-3 in mononuclear cells when compared with the baseline and the placebo. PCE intake also suppressed plasma concentrations of TNF-alpha, IL-6, and C-reactive protein. There was no change in these indices in the control group given placebo. CONCLUSIONS: The PCE-containing resveratrol has a comprehensive suppressive effect on oxidative and inflammatory stress.
Authors: P Dandona; P Mohanty; H Ghanim; A Aljada; R Browne; W Hamouda; A Prabhala; A Afzal; R Garg Journal: J Clin Endocrinol Metab Date: 2001-01 Impact factor: 5.958
Authors: E Migliaccio; M Giorgio; S Mele; G Pelicci; P Reboldi; P P Pandolfi; L Lanfrancone; P G Pelicci Journal: Nature Date: 1999-11-18 Impact factor: 49.962
Authors: B Emanuelli; P Peraldi; C Filloux; C Chavey; K Freidinger; D J Hilton; G S Hotamisligil; E Van Obberghen Journal: J Biol Chem Date: 2001-10-16 Impact factor: 5.157
Authors: Konrad T Howitz; Kevin J Bitterman; Haim Y Cohen; Dudley W Lamming; Siva Lavu; Jason G Wood; Robert E Zipkin; Phuong Chung; Anne Kisielewski; Li-Li Zhang; Brandy Scherer; David A Sinclair Journal: Nature Date: 2003-08-24 Impact factor: 49.962
Authors: Joseph J Senn; Peter J Klover; Irena A Nowak; Teresa A Zimmers; Leonidas G Koniaris; Richard W Furlanetto; Robert A Mooney Journal: J Biol Chem Date: 2003-01-30 Impact factor: 5.157
Authors: M Irfan Ali; Pimonrat Ketsawatsomkron; Eric J Belin de Chantemele; James D Mintz; Kenjiro Muta; Christina Salet; Stephen M Black; Michel L Tremblay; David J Fulton; Mario B Marrero; David W Stepp Journal: Circ Res Date: 2009-09-24 Impact factor: 17.367
Authors: Anna Csiszar; Danuta Sosnowska; Mingyi Wang; Edward G Lakatta; William E Sonntag; Zoltan Ungvari Journal: J Gerontol A Biol Sci Med Sci Date: 2012-01-04 Impact factor: 6.053
Authors: Richard D Semba; Luigi Ferrucci; Benedetta Bartali; Mireia Urpí-Sarda; Raul Zamora-Ros; Kai Sun; Antonio Cherubini; Stefania Bandinelli; Cristina Andres-Lacueva Journal: JAMA Intern Med Date: 2014-07 Impact factor: 21.873
Authors: Yolanda Jimenez-Gomez; Julie A Mattison; Kevin J Pearson; Alejandro Martin-Montalvo; Hector H Palacios; Alex M Sossong; Theresa M Ward; Caitlin M Younts; Kaitlyn Lewis; Joanne S Allard; Dan L Longo; Jonathan P Belman; Maria M Malagon; Placido Navas; Mitesh Sanghvi; Ruin Moaddel; Edward M Tilmont; Richard L Herbert; Christopher H Morrell; Josephine M Egan; Joseph A Baur; Luigi Ferrucci; Jonathan S Bogan; Michel Bernier; Rafael de Cabo Journal: Cell Metab Date: 2013-10-01 Impact factor: 27.287
Authors: Joao Tomé-Carneiro; Mar Larrosa; Antonio González-Sarrías; Francisco A Tomás-Barberán; María Teresa García-Conesa; Juan Carlos Espín Journal: Curr Pharm Des Date: 2013 Impact factor: 3.116